TENAX THERAPEUTICS INC's ticker is and the CUSIP is 88032L209. A total of 21 filers reported holding TENAX THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6 | -99.9% | 51,212 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -46.7% | 51,212 | 0.0% | 0.00% | – |
| Q2 2022 | $15,000 | -63.4% | 51,212 | 0.0% | 0.00% | – |
| Q1 2022 | $41,000 | -22.6% | 51,212 | 0.0% | 0.00% | – |
| Q4 2021 | $53,000 | -41.1% | 51,212 | 0.0% | 0.00% | – |
| Q3 2021 | $90,000 | -18.9% | 51,212 | 0.0% | 0.00% | – |
| Q2 2021 | $111,000 | +12.1% | 51,212 | -2.1% | 0.00% | – |
| Q1 2021 | $99,000 | +62.3% | 52,301 | +58.5% | 0.00% | – |
| Q4 2020 | $61,000 | +22.0% | 32,999 | 0.0% | 0.00% | – |
| Q3 2020 | $50,000 | +72.4% | 32,999 | 0.0% | 0.00% | – |
| Q2 2020 | $29,000 | +61.1% | 32,999 | -0.1% | 0.00% | – |
| Q1 2020 | $18,000 | -80.4% | 33,019 | -50.1% | 0.00% | – |
| Q4 2019 | $92,000 | +135.9% | 66,136 | +100.0% | 0.00% | – |
| Q3 2019 | $39,000 | -13.3% | 33,068 | 0.0% | 0.00% | – |
| Q2 2019 | $45,000 | -18.2% | 33,068 | +19.6% | 0.00% | – |
| Q1 2019 | $55,000 | -16.7% | 27,658 | -50.0% | 0.00% | – |
| Q4 2018 | $66,000 | – | 55,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |